DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Merck & Co., Inc.

NYSE: MRK


company name or ticker
Company Photos
(Click to zoom)

Pick Your Poison: Overweight or High Cholesterol

Researchers discover that cholesterol-lowering Zocor hindered positive effects of exercise for obese and overweight adults.

The New Generic-Drug Battle Front

One generic pharmaceutical company is determined to chance consumer habits.

Dow Jumps on Virtuous Cycle

Conusmer confidence numbers sent stocks soaring again as the Dow and S&P 500 finished the week at record highs.

Oncothyreon A Speculative Buy

3 Most Important Upcoming FDA Decisions of 2013

The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.

Industrial Stocks Drive Dow’s 112-Point Day

Another week of net gains and fresh highs for blue-chip stocks as confidence rises.

Merck to Present at the UBS Global Healthcare Conference

Why Stocks Are Continuing Their Climb

A spike in consumer confidence is lifting the markets today.

Strong Consumer Sentiment Pulls Markets Higher

In a consumer-driven economy, when Americans are happy, business usually performs well.

Dow Today: Merck (MRK) Lower

See More Articles...